Comparative cardiovascular effects of different progestins in menopause

International Journal of Fertility and Women's Medicine

Volumn 46, Issue 5, 2001, Pages 248-256

  Rosano, Giuseppe M C ^a   Fini, Massimo ^a  

^a Res U Dept Med Sci S R   (Italy)

Author keywords

Adjunctive use; Androgenic; HRT; Non androgenic; Progestins; Side effects

Indexed keywords

CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; PRAVASTATIN; PROGESTERONE RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; MENOPAUSE; MULTICENTER STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIPIDS; MENOPAUSE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGESTINS; RANDOMIZED CONTROLLED TRIALS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0035702683     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cardiovascular mortality and noncontraceptive use of estrogen in women results from Lipid Research Clinics Program Follow-up Study
2. How progestins compromise the cardioprotective effects of estrogens
3. Effects of pharmacologic agents used during menopause: Impact on lipids and lipoproteins
4. The epidemiology of coronary heart disease and estrogen replacement therapy in postmenopausal women
5. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
6. Oestrogens and the heart
7. Effect of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
8. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
9. The effect of hormone replacement therapy alone or in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women in coronary artery disease
10. A comparison of estrogen replacement, pravastatin and combined treatment in the management of hypercholesterolemia in postmenopausal women
11. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilatation in postmenopausal women with coronary artery disease
12. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
13. Effect of estrogen replacement on the progression of coronary atherosclerosis
14. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries
15. Effects of estrogens and progestins on the pathogenesis of atherosclerosis in nonhuman primates
16. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy
17. 17β estradiol lessens angina in postmenopausal women with syndrome X
18. Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
19. The risk of acute myocardial infarction after estrogen and estrogen-progestogen replacement
20. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
21. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women